Application
Fig1: Paraformaldehyde-fixed, paraffin embedded (rat brain); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37℃ for 30min; Antibody incubation with (MCT1) Polyclonal Antibody, Unconjugated (ER1912-87) at 1:400 overnight at 4℃, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Application
Fig2: Blank control: MCF7 Cells(blue).
Primary Antibody: Rabbit Anti-MCT1/AF647 Conjugated antibody (ER1912-87-AF647), Dilution: 1μg in 100 μL 1X PBS containing 0.5% BSA;
Isotype Control Antibody: Rabbit IgG/FITC(orange) ,used under the same conditions.
Application
Fig3: Sample:HepG2 (Human)cell Lysate at 40 ug
Primary: Anti-MCT1(ER1912-87)at 1/300 dilution
Secondary: IRDye800CW Goat Anti-RabbitIgG at 1/20000 dilution
Predicted band size: 55kD
Observed band size: 55kD
WB
(g–p) Results from western blot analysis showed that apelin-13 promoted the expression of GLUT1, PKM2, LDHA, MCT1, and MCT4 in dose- and time-dependent manners for 24 hr (data were presented as mean ± SEM, n = 3–4; *p < 0.05, **p < 0.01, and ***p < 0.001 vs. control).
WB
(d–h) Western blot analysis showed that apelin-13 promoted the expression of GLUT1, PKM2, LDHA, MCT1, and MCT4, however, F13A reversed apelin-13-induced GLUT1, PKM2, LDHA, MCT1, and MCT4 expression (data were presented as mean ± SEM, n = 4–5; *p < 0.05, **p < 0.01, and ***p < 0.001 vs.